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OBJECTIVE: To present our experience in the management of patients with infected pancreatic necrosis without
drainage.
METHODS: The records of patients with pancreatic necrosis admitted to our facility from 2011 to 2015 were
retrospectively reviewed.
RESULTS:We identified 61 patients with pancreatic necrosis. Six patients with pancreatic necrosis and gas in the
retroperitoneum were treated exclusively with clinical support without any type of drainage. Only 2 patients
had an APACHE II score48. The first computed tomography scan revealed the presence of gas in 5 patients. The
Balthazar computed tomography severity index score was 49 in 5 of the 6 patients. All patients were treated
with antibiotics for at least 3 weeks. Blood cultures were positive in only 2 patients. Parenteral nutrition was not
used in these patients. The length of hospital stay exceeded three weeks for 5 patients; 3 patients had to be
readmitted. A cholecystectomy was performed after necrosis was completely resolved; pancreatitis recurred in
2 patients before the operation. No patients died.
CONCLUSIONS: In selected patients, infected pancreatic necrosis (gas in the retroperitoneum) can be treated
without percutaneous drainage or any additional surgical intervention. Intervention procedures should be
performed for patients who exhibit clinical and laboratory deterioration.
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’ INTRODUCTION
Acute pancreatitis is a very prevalent disease worldwide.
In the United States alone, 200,000 patients are admitted to
the hospital annually due to pancreatitis, and its incidence is
increasing (1). Approximately 20% of patients develop severe
disease with pancreatic necrosis, which is complicated with
the presence of infection in 30% of these patients (2,3). In
the last two decades, significant changes have occurred in the
treatment of infected pancreatic necrosis. Namely, surgical
intervention has been postponed and minimally invasive
techniques have been introduced (4-6).
Despite advances in the treatment of acute pancreatitis,
the morbidity and mortality of this disease are still very
high, particularly when pancreatic necrosis is associated with
infection. Failure of one or more organs develops in 40% of
patients with pancreatic necrosis, and mortality exceeds 20%
when the necrotic area becomes infected (3,5,7).
Although infected pancreatic necrosis can be devastat-
ing and can have a poor prognosis, the clinical conditions of
patients can be quite variable. Although many patients are
critically ill and develop multiple organ dysfunctions, some
patients remain clinically healthy (8,9).
Typically, infected pancreatic necrosis must be treated with
an invasive procedure. The treatment of infected necrosis can
be accomplished by endoscopic, surgical, or percutaneous
intervention. In the past, surgical intervention was the first or
only option. However, recent studies have advocated the
so-called "step-up approach". In this approach, treatment
begins with minimally invasive procedures, and operative
intervention is performed only when the initial procedure is
unsuccessful (2,5,10-13). Percutaneous drainage of infected
pancreatic necrotic tissue reduces the need for surgery in up
to 35% of cases (11,14).
The timing of intervention in patients with infected pan-
creatic necrosis has been widely discussed. The current opin-
ion is that later intervention results in a better outcome (6,13).
In some situations, the intervention for drainage may be
delayed to the point that the patient recovers completely,
and no invasive procedure is required. Various studies haveDOI: 10.6061/clinics/2017(02)04
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demonstrated that selected patients with infected pancreatic
necrosis can be successfully managed exclusively by clinical
treatment (4,15-17). The objective of this paper is to present
our experience in the management of patients with pancrea-
tic necrosis and gas in the retroperitoneum who were treated
exclusively with antibiotics and did not require any type of
drainage.
’ MATERIALS AND METHODS
The General Surgery Service of Hospital das Clínicas of the
University of São Paulo School of Medicine maintains a
prospective database with detailed records of patients admit-
ted with a diagnosis of severe acute pancreatitis. We retro-
spectively reviewed the records of all patients admitted to
our hospital from January 2011 to June 2015 with acute
pancreatitis and infected pancreatic necrosis.
We do not perform fine needle aspiration to determine the
presence of infection. The diagnosis of infection of pancreatic
necrosis was documented by the presence of gas in the retro-
peritoneum on computed tomography (CT) or by positive
cultures after the drainage of pancreatic collections in
patients who maintained clinical or laboratory signs of
infection (18).
We identified 61 consecutive patients with a diagnosis of
necrotizing pancreatitis. Forty patients were treated exclu-
sively with clinical support. Eleven patients were initially
treated by percutaneous drainage; seven of these patients
were subsequently treated with open surgical necrosectomy.
Necrosectomy was the first intervention in 10 patients. In the
subgroup of 40 patients treated without drainage or surgery,
we identified 6 patients with pancreatic necrosis and gas in
the retroperitoneum. These 6 patients are the focus of the
current study (Figure 1).
The following patient data were reviewed and analyzed:
age, gender, aetiology of pancreatitis, length of symptoms
before hospital admission, previous visits to the emergency
room (ER) at other facilities, Acute and Physiologic and Chronic
Health Evaluation II (APACHE II) score on admission, length
of hospital stay, length of readmission, number of CT scans
performed, modified Balthazar CT severity index score (19),
the length of antibiotic therapy, positive blood cultures, the
need for enteral feeding, white cell count, and C-reactive
protein (CRP) (Tables 1 and 2).
’ RESULTS
Tables 1 and 2 summarize the main characteristics of the
6 patients. In one patient, the aetiology of pancreatitis was
alcoholism. In all the other patients, pancreatitis occurred
secondary to gallstones. One of these 5 patients also had
intraductal mucinous neoplasms with calcification in the
pancreatic head.
Only one patient was treated by our service beginning from
the onset of symptoms. The other 5 patients were previously
treated at other facilities and were admitted to our service more
than 2 weeks after the beginning of the disease.
All patients were clinically healthy at the time without any
organ dysfunction. Only two patients had an APACHE II
score of 48. The maximum CRP levels were 372 mg/L in
one patient and 4150 mg/L in 3 patients. Leucocytosis was
present in only one patient.
The first CT performed in our service revealed gas in all
but 1 patient (case 5) (Figure 2). All patients underwent at
Figure 1 - Management and mortality of patients with necrotizing pancreatitis.
Table 1 - Demographic and clinical characterization of patients.









length of stay (days)
1 69 M Cholelithiasis 21 + 24 5/30
2 17 M Cholelithiasis 14 + 32 -
3 58 F Cholelithiasis 20 + 5 -
4 69 F Cholelithiasis 20 + 36 -
5 40 M Cholelithiasis 10 - 23 15/22
6 40 M Alcohol 23 + 12 8/5
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1 6 117 10.62 6 9 Streptococcus anginosus +
2 5 159 20.12 5 9 Micrococcus +
3 5 30 9.47 3 9 - -
4 8 198 7.86 4 9 - +
5 10 372 10.88 4 9 - +
6 0 78 12.00 4 5 - -
Figure 2 - CT scan, case 5. A: First exam, 10 days after the onset of symptoms: extensive necrosis of the body and tail of the pancreas;
calcification in the pancreatic head, suggesting the presence of intraductal neoplasia. B: After 30 days of follow-up (increase in CRP and
fever): gas in the full extent of the area of pancreatic necrosis. C: 5 months after hospital discharge: no pancreatic necrosis or collection.
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least 3 CT scans (Figures 2, 3 and 4). Balthazar’s CT severity
index score was 9 in 5 patients (Table 2).
All patients were treated with antibiotics due to the presence
of gas in the retroperitoneum. The initial antibiotic therapy
consisted of ciprofloxacin plus metronidazole in all patients.
In 1 patient, this scheme was changed to imipenem due to the
presence of a persistent fever. All patients received antibiotics for
at least 3 weeks. Only 2 patients had positive blood cultures.
No patient received parenteral nutrition. Four patients were
treated with enteral nutrition through tubes placed endosco-
pically at a location beyond the angle of Treitz.
The length of the hospital stay exceeded 3 weeks for all
(23-36 days) but 1 patient (case 6). Three patients were
readmitted due to persistent vomiting and fever. All read-
mitted patients were again treated with antibiotics. Two
patients received nutrition through enteral tubes.
Figure 3 - CT scan, case 4. A: First exam, 3 weeks after the onset of symptoms: extensive pancreatic necrosis with a large amount of gas
in the body and tail of the pancreas. B: After 60 days of follow-up: a small decrease in the collection of gas is noted. C: 4 months after
hospital discharge: atrophy of pancreatic parenchyma.
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A cholecystectomy was performed in the 5 patients diag-
nosed with cholelithiasis after control CT scans revealed com-
plete recovery of pancreatic necrosis. Two patients (cases 4
and 5) experienced recurrence of pancreatitis with infected
pancreatic necrosis approximately six months after hospital
discharge. The patients were waiting to receive a cholecys-
tectomy at that time. Both patients exhibited an uneventful
recovery from this new episode and have subsequently
received surgery. No deaths occurred in this series.
’ DISCUSSION
This study analyzed six patients with infected pancreatic
necrosis confirmed by the presence of gas in the retro-
peritoneum who were treated exclusively with antibiotics.
The spectrum of clinical presentations of patients with acute
pancreatitis can vary widely and can be disproportionate to
CT findings. Therefore, treatment should be individualized
and dictated mainly by the clinical condition of the patient.
Figure 4 - CT scan, case 3 A: First exam, 3 weeks after the onset of symptoms: pancreatic necrosis with gas throughout the body and the
tail of the pancreas. B: After 50 days of follow-up: significant necrosis and gas are still present. C: 3 months after hospital discharge: no
pancreatic necrosis or collection.
91
CLINICS 2017;72(2):87-94 Pancreatic Necrosis and Gas in the Retroperitoneum
Rasslan R et al.
In our study, only 2 patients had an APACHE score 48,
whereas the CT index score, as proposed by Balthazar (19),
was 9 in 5 patients. The systemic conditions do not always
reflect the severity of pancreatic and peripancreatic compro-
mise. Lankisch et al. (20) demonstrated that the APACHE II
score was not the best tool to evaluate the presence and
severity of pancreatic necrosis. The APACHE II score has a
sensitivity of 36% and a specificity of 72%. Our study also
demonstrated that only 2 patients had an APACHE II score
48 despite extensive pancreatic necrosis with gas.
In 2012, Dellinger et al. (8) proposed a new classification of
pancreatitis that takes into account both systemic and local
conditions. The Atlanta classification includes only systemic
conditions and was revised in 2013 (21). The new classifica-
tion includes moderate acute pancreatitis, a condition in
which the patient has pancreatic or peripancreatic necrosis
but no organ dysfunction (9).
The classic treatment of infected pancreatic necrosis is
operative intervention with necrosectomy. This invasive proce-
dure has a high incidence of complications and mortality
(13-26%), even in specialized services (4,6,22). Therefore,
minimally invasive interventions, mainly percutaneous and
endoscopic drainage, have been proposed (2). The pancrea-
titis, necrosectomy versus step up approach study (PANTER)
(5,10,23,24) compared patients randomized to receive open
necrosectomy or minimally invasive procedures (endoscopic
or percutaneous drainage) as the first intervention. The group
that was initially treated with minimally invasive drainage
exhibited a reduced incidence of complications and multiple
organ failure. Hollemans et al. (11) demonstrated that percuta-
neous treatment was the only intervention necessary for many
patients initially treated by this "step-up approach". The need
for operative treatment was eliminated in 35% of their patients.
These data are similar to the results of some retrospective
studies that have demonstrated that percutaneous drainage
obviates the need for surgery in up to half of all cases (25,26).
Due to increased use of the "step-up approach", open
necrosectomy has been performed less frequently. However,
Madenci et al. (27) reported a mortality rate of only 8.8% in
patients who underwent pancreatic open necrosectomy, but
only 17% of the patients underwent percutaneous drainage
before the operation.
When used as the only treatment or along with a mini-
mally invasive procedure when feasible, medicinal therapy
may avoid the complications associated with open necro-
sectomy, such as new onset or worsening of multiple organ
dysfunction, bleeding, fistulae, pancreatic insufficiency and
incisional hernia (4,27,28).
In 1996, Dubner et al. (17) first reported the treatment of
3 patients with infected pancreatic necrosis without invasive
interventions. The infection was diagnosed by fine needle
aspiration, and patients were treated with antibiotics alone.
In 2005, Runzi et al. (16) published a study of 28 patients
with infected pancreatic necrosis. Sixteen of these patients
received no operative treatment. Six patients recovered
uneventfully. The other patients exhibited multiple organ
failure. The mortality rate was 12.5%. One drawback of the
aforementioned study was that only 3 patients underwent
percutaneous drainage, although 10 patients had multiple
organ dysfunction.
Lee et al. (15) also described non-operative treatment for
infected pancreatic necrosis in 31 patients. In their study, 74%
of patients were initially treated with minimally invasive
drainage. Four of these patients underwent open necrosectomy
after percutaneous or endoscopic drainage. Eight patients
(25%) were treated exclusively with antibiotics, and only
1 patient died.
We believe that early treatment with antibiotics must be
the initial choice for all patients with infected pancreatic
necrosis. If the patient presents with signs of clinical wors-
ening, a minimally invasive procedure should be promptly
considered.
After the publication of the PANTER study (5,10,23), the
indication of percutaneous drainage became more liberal,
but some patients can be successfully treated exclusively
with antibiotics (4,15-17).
Percutaneous drainage and open necrosectomy are both
associated with a high incidence of pancreatic fistulae (27),
and in some series, the incidence is up to 50%. This finding
may justify a tendency to postpone the use of invasive
treatment in patients with infected pancreatic necrosis (29).
Regarding the treatment of infected pancreatic necrosis,
the timing of the intervention may have a significant impact
in the outcome (13,30). Götzinger et al. (6) observed a mor-
tality rate of 46% in patients who received surgery during the
first 3 weeks after the diagnosis of pancreatitis versus a
mortality rate of 25% in patients who underwent surgery
after this period.
We believe that invasive treatment of infected pancreatic
necrosis should be delayed as long as possible. Drainage
should be conducted only if clinical and laboratory findings
indicate that the patient is deteriorating despite the use of
appropriate antibiotic therapy. Currently, in our service,
antibiotics are only used for patients with documented or
presumed infected necrosis. We no longer use antibiotics
for infection prevention, even when extensive necrosis is
observed (31,32). The length of antibiotic therapy remains an
open issue. Runzi et al. (16) administered antibiotics for
at least 8 weeks. We believe that the treatment of infected
necrosis requires prolonged antibiotic therapy regardless
of the use of interventional procedures. We advocate that
antibiotic use should be continued for at least 3 weeks.
The diagnosis of infection in patients with pancreatic
necrosis remains a substantial challenge. In the past, the
pressure to document necrosis infection was higher because
physicians believed that surgical treatment should be imme-
diately instituted once an infection was diagnosed (13). The
presence of gas in the retroperitoneal collection is considered
to indicate the presence of an infection. Infection can also be
diagnosed by the presence of microorganisms in cultures
of material collected from the necrotic area by fine needle
aspiration or during drainage or open surgery. However,
the sensitivity of fine needle aspiration is only 50 to 70%.
The sensitivity may be low due to the use of preventive anti-
biotics in some cases (2,30). We consider fine needle aspira-
tion to be an invasive procedure that involves the transfer
of the patient from the intensive care unit to the radiology
department. In patients who maintain organ dysfunction
despite the administration of appropriate therapy, the necro-
tic area should be presumed to be infected. It is believed that
many patients with pancreatic necrosis who improve after
antibiotic therapy have infected pancreatic necrosis that is
not documented (2,18,33).
Regardless of the type of therapy chosen, the treatment of
infected pancreatic necrosis requires a prolonged hospital
stay (5,15,27). In patients treated with antibiotics alone, the
length of the hospital stay is also very long and comparable
to that of patients who undergo minimally invasive or
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surgical procedures (5,15). Van Santvoort et al. (5) reported
no difference in the length of hospital stay in patients who
received the ‘‘step-up approach’’ compared to patients in
whom surgical treatment was the first intervention. In our
study, the length of the hospital stay exceeded three weeks
for all patients. In addition, 3 patients required early hospital
readmission.
Extensive pancreatic necrosis, particularly when an infec-
tion is present, increases the risk of bleeding from large
splanchnic vessels. This finding explains why many surgeons
feel uncomfortable if they do not intervene in cases of infected
necrosis. However, bleeding usually stops spontaneously
due to the rigidity of the local inflammatory tissues (29). In
our series of 61 patients, 1 patient with infected pancreatic
necrosis who was initially managed only with antibiotics
was diagnosed as having a colon perforation secondary to
the thrombosis of colic vessels 5 weeks after treatment
initiation. This case emphasizes the need for close and very
careful monitoring of patients, possibly for long periods of
time. Some may argue that this complication could have
been avoided if drainage had been performed earlier during
the course of pancreatitis.
This study shows that, in selected cases, infected pancrea-
tic necrosis with gas in the retroperitoneum requires neither
immediate percutaneous drainage nor surgical intervention.
These procedures should be reserved for patients who develop
signs of clinical and laboratory deterioration. Some patients
can be safely treated with antibiotics alone.
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